242 related articles for article (PubMed ID: 12878900)
21. ST-elevation myocardial infarction: New Zealand management guidelines.
;
N Z Med J; 2005 Oct; 118(1223):U1679. PubMed ID: 16224503
[No Abstract] [Full Text] [Related]
22. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
23. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
Sauer H; Leschke M
Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
[No Abstract] [Full Text] [Related]
24. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
25. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
26. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Steinhubl S; Roe MT
Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
[TBL] [Abstract][Full Text] [Related]
27. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
[TBL] [Abstract][Full Text] [Related]
28. Coronary thrombosis and myocardial infarction as the initial manifestation of protein C deficiency in a 20-year-old man.
Eshtehardi P; Ghassemi-Kakroodi P; Garachemani A; Eslami M; Moayed DA
Heart Lung; 2011; 40(4):e112-4. PubMed ID: 21481934
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
Martinez-Ojeda J; Martinez-Toro J
Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
[TBL] [Abstract][Full Text] [Related]
30. Current challenges and directions in antithrombotic therapy.
Van de Werf F
Timely Top Med Cardiovasc Dis; 2008 Jan; 12():E2. PubMed ID: 18392216
[No Abstract] [Full Text] [Related]
31. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
[TBL] [Abstract][Full Text] [Related]
32. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
Cannon CP
Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
[TBL] [Abstract][Full Text] [Related]
33. Do patients with acute myocardial infarction benefit from treatment with clopidogrel?
Worster A; Keim SM; Vadera R; Rosen P
J Emerg Med; 2008 May; 34(4):479-83; discussion 483. PubMed ID: 18226876
[TBL] [Abstract][Full Text] [Related]
34. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
[TBL] [Abstract][Full Text] [Related]
35. Sweet and sticky: diabetic platelets, enhanced reactivity, and cardiovascular risk.
Simon DI; Schmaier AH
J Am Coll Cardiol; 2007 Oct; 50(16):1548-50. PubMed ID: 17936153
[No Abstract] [Full Text] [Related]
36. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
[TBL] [Abstract][Full Text] [Related]
37. Aspirin as an emergency drug.
Wynn RL
Gen Dent; 2009; 57(5):464-6. PubMed ID: 19903635
[No Abstract] [Full Text] [Related]
38. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
O'Donoghue M; Wiviott SD
Circulation; 2006 Nov; 114(22):e600-6. PubMed ID: 17130347
[No Abstract] [Full Text] [Related]
39. Accelerating time to reperfusion in acute myocardial infarction: prehospital and emergency department strategies, systems of care, and pharmacologic interventions.
Ornato JP
Rev Cardiovasc Med; 2006; 7 Suppl 4():S49-60. PubMed ID: 17224891
[TBL] [Abstract][Full Text] [Related]
40. [Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
Füessl HS
MMW Fortschr Med; 2004; 146 Suppl 1():3. PubMed ID: 15493407
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
